Bio-Techne Announces Changes to its Leadership Team

robot
Abstract generation in progress

Bio-Techne Corporation (NASDAQ: TECH) announced leadership changes, with Dr. Matt McManus stepping down as President of the Diagnostics and Spatial Biology Segment, effective March 1, 2026. Steve Crouse, currently Senior Vice President of Analytical Solutions, will succeed him. This transition aims to leverage Crouse’s extensive experience to drive the company’s next phase of growth alongside President of Protein Sciences, Will Geist.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский язык
  • Français
  • Deutsch
  • Português (Portugal)
  • ภาษาไทย
  • Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)